Tag Archives: Pharma

Rise in IPOs Eases Pharma's Investment Woes

Private equity and venture capital (PEVC) deal activity decreased from 1063 in 2010 to 480 in 2013, according to a new Frost & Sullivan report. And the pharma, biotech and healthcare equipment sectors experienced a much sharper decline in investor interest than the healthcare technology and provider segments, the report adds. But there is a […]
Posted in Biotech, Deals, Global, healthcare | Also tagged , , , , | Leave a comment

HBA's 2014 Woman of the Year: Broadening the Base

HBA’s 2014 Woman of the Year:  Broadening the Base To mark its 25th year in recognizing female leadership in the tough competitive ranks of biopharma, the Healthcare Businesswomen’s Association [HBA] is opting for a breakout triple play.  When the group convenes on May 1 in New York for its annual Woman of the Year [WOTY] […]
Posted in Events, healthcare, leadership, People | Also tagged , , , , | Leave a comment

Indian Pharma's Fraudulent Job Applicants

Thirty-five out of every 100 job applicants in the pharmaceutical or clinical trial space in India “are lying about their credentials”, says a report by Delhi-based employee screening firm AuthBridge.
Posted in Emerging Markets, Global | Also tagged , , | Leave a comment

How Good for UK Pharma is the European Union?

As the United Kingdom debate about whether to stay in the European Union becomes more bitter and intense, an insight into how EU membership impacts on medicines and pharmaceuticals has appeared from a British politician who was until recently the UK Government Adviser on Life Sciences, George Freeman. His view—which is less than rosy—is worth […]
Posted in Europe, Global, Guest Blog, Regulatory | Also tagged , , , , | 1 Comment

Obamacare: Questions for Pharma in 2014

Tom Norton outlines the Obamacare-related questions that are likely to be of concern to pharma companies in the U.S. this year. I t’s expected that about 35 new FDA approved prescription drugs will arrive on the market in 2014. What are the chances that these new medications will be utilized by Obamacare health programs?  Given […]
Posted in Guest Blog, healthcare, Op-Ed, Regulatory | Also tagged , , , , | 2 Comments
  • Categories

  • Meta